Amgen (NASDAQ:AMGN) reported quarterly earnings of $3.70 per share which missed the analyst consensus estimate of $4.05 by 8.64 percent. This is a 11.27 percent decrease over earnings of $4.17 per share from the same period last year. The company reported quarterly sales of $5.90 billion which missed the analyst consensus estimate of $6.25 billion by 5.60 percent. This is a 4.24 percent decrease over sales of $6.16 billion the same period last year.
Amgen Q1 EPS $3.70 Misses $4.05 Estimate, Sales $5.90B Miss $6.25B Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.